Robert Tiballi is an Infectious Disease physician affiliated with University of Michigan–Ann Arbor. OpenAlex indexes 7 publications with 569 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2144 Foothill Rd
Elgin, IL 601235871
Telephone
847-741-4376Provider last certified this registry record 19 Dec 2024.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20228 payments$17,333openpaymentsdata.cms.gov ↗
- Takeda Pharmaceuticals U.S.A., Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
83.6%Cephalosporin Antibacterial24.7%Ceftriaxone100%Part D<11 patientsPenicillins with extended spectrum23.3%Amoxicillin-Clavulanate Potass100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
16.4%SGLT2 inhibitor16.4%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods
Diagnostic Microbiology and Infectious Disease
1995 - Torulopsis glabrata: azole susceptibilities by microdilution colorimetric and macrodilution broth assays
Journal of Clinical Microbiology
1995
Similar KOLs
Other experts from the same institution or the same specialty.
Arnold Coran, MD
University of Michigan–Ann Arbor
Monica Starkman, MD
University of Michigan–Ann Arbor
Powel Kazanjian, MD
University of Michigan–Ann Arbor
Cecilia Peabody, MD
University of Michigan–Ann Arbor
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”